Johnston KW, Rutherford RB, Tilson MD, Shah DM, Hollier L, Stanley JC. Suggested standards for reporting on arterial aneurysms. Subcommittee on Reporting Standards for Arterial Aneurysms, Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery and North American Chapter, International Society for Cardiovascular Surgery. J Vasc Surg. 1991;13(3):452–8.

Karrowni W, Dughman S, Hajj GP, Miller FJ (2011) Statin therapy reduces growth of abdominal aortic aneurysms. J Investig Med 59(8):1239–1243

Article  CAS  PubMed  PubMed Central  Google Scholar 

Norman PE, Powell JT (2010) Site specificity of aneurysmal disease. Circulation 121(4):560–568

Article  CAS  PubMed  Google Scholar 

Rahman MNAA, Khan JA, Mazari FA, Mockford K, McCollum PT, Chetter IC (2011) A randomized placebo controlled trial of the effect of preoperative statin use on matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in areas of low and peak wall stress in patients undergoing elective open repair of abdominal aortic aneurysm. Ann Vasc Surg 25(1):32–38

Article  PubMed  Google Scholar 

Mosorin M, Niemela E, Heikkinen J, Lahtinen J, Tiozzo V, Satta J, Juvonen T, Biancari F (2008) The use of statins and fate of small abdominal aortic aneurysms. Interact Cardiovasc Thorac Surg 7(4):578–581

Article  PubMed  Google Scholar 

Michel JB, Martin-Ventura JL, Egido J, Sakalihasan N, Treska V, Lindholt J et al (2011) Novel aspects of the pathogenesis of aneurysms of the abdominal aorta in humans. Cardiovasc Res 90(1):18–27

Article  CAS  PubMed  Google Scholar 

Joviliano EE, Ribeiro MS, Tenorio EJ (2017) MicroRNAs and current concepts on the pathogenesis of abdominal aortic aneurysm. Braz J Cardiovasc Surg 32(3):215–224

PubMed  PubMed Central  Google Scholar 

Abisi S, Burnand KG, Humphries J, Waltham M, Taylor P, Smith A (2007) Effect of statins on proteolytic activity in the wall of abdominal aortic aneurysms. Br J Surg 95(3):333–337

Article  Google Scholar 

McMillan WD, Tamarina NA, Cipollone M, Johnson DA, Parker MA, Pearce WH (1997) Size matters: the relationship between MMP-9 expression and aortic diameter. Circulation 96(7):2228–2232

Article  CAS  PubMed  Google Scholar 

Curci JA, Thompson RW (2004) Adaptive cellular immunity in aortic aneurysms: cause, consequence, or context? J Clin Investig 114(2):168–171

Article  CAS  PubMed  PubMed Central  Google Scholar 

Strachan D (1991) Predictors of death from aortic aneurysm among middle aged men: the Whitehall study. Br J Surg 78:401–404

Article  CAS  PubMed  Google Scholar 

Kleemann R, Princen HM, Emeis JJ, Jukema JW, Fontijn RD, Horrevoets AJ, Kooistra T, Havekes LM (2003) Rosuvastatin reduces atherosclerosis development beyond and independent of its plasma cholesterol-lowering effect in APOE*3-Leiden transgenic mice: evidence for antiinflammatory effects of rosuvastatin. Circulation 108:1368–1374

Article  CAS  PubMed  Google Scholar 

Verschuren L, Kleemann R, Offerman EH, Szalai AJ, Emeis SJ, Princen HM, Kooistra T (2005) Effect of low dose atorvastatin versus diet-induced cholesterol lowering on atherosclerotic lesion progression and inflammation in apolipoprotein E*3-Leiden transgenic mice. Arterioscler Thromb Vasc Biol 25:161–167

Article  CAS  PubMed  Google Scholar 

Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses. 2012. https://www.ohrica/programs/clinical_epidemiology/oxfordasp.

Evans J, Powell JT, Schwalbe E, Loftus IM, Thompson MM (2007) Simvastatin attenuates the activity of Matrix Metalloprotease-9 in aneurysmal aortic tissue. Eur J Vasc Endovasc Surg 34(3):302–303

Article  CAS  PubMed  Google Scholar 

Hurks R, Hoefer IE, Vink A, Pasterkamp G, Schoneveld A, Kerver M, de Vries J-PPM, Tangelder MJ, Moll FL (2010) Different effects of commonly prescribed statins on abdominal aortic aneurysm wall biology. Eur J Vasc Endovasc Surg 39(5):569–576

Article  CAS  PubMed  Google Scholar 

O’Donnell TFX, Deery SE, Shean KE, Mittleman MA, Darling JD, Eslami MH, DeMartino RR, Schermerhorn ML (2018) Statin therapy is associated with higher long-term but not perioperative survival after abdominal aortic aneurysm repair. J Vasc Surg 68(2):392–399

Article  PubMed  PubMed Central  Google Scholar 

Raux M, Cochennec F, Becquemin J-P (2012) Statin therapy is associated with aneurysm sac regression after endovascular aortic repair. J Vasc Surg 55(6):1587–1592

Article  PubMed  Google Scholar 

Stein LH, Berger J, Tranquilli M, Elefteraides JA (2013) Effect of statin drugs on thoracic aortic aneurysms. Am J Cardiol 112(8):1240–1245

Article  CAS  PubMed  Google Scholar 

Sukhija R, Aronow WS, Sandhu R, Kakar P, Babu S (2006) Mortality and size of abdominal aortic aneurysm at long-term follow-up of patients not treated surgically and treated with and without statins. Am J Cardiol 97(2):279–280

Article  PubMed  Google Scholar 

Wilson WRW, Evans J, Bell PRF, Thompson MM (2005) HMG-COA reductase inhibitors (statins) decrease MMP-3 and MMP-9 concentrations in abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 30(3):259–262

Article  CAS  PubMed  Google Scholar 

Kalyanasundaram A, Elmore JR, Manazer JR et al (2006) Simvastatin suppresses experimental aortic aneurysm expansion. J Vasc Surg 43(117):e39

Google Scholar 

Freestone T, Turner RJ, Coady A, Higman DJ, Greenhalgh RM, Powell JT (1995) Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 15:1145–1151

Article  CAS  PubMed  Google Scholar 

Elmore JR, Keister BF, Franklin DP, Youkey JR, Carey DJ (1998) Expression of matrix metalloproteinases and TIMPs in human abdominal aortic aneurysms. Ann Vasc Surg 12:221–228

Article  CAS  PubMed  Google Scholar 

Goodall S, Crowther M, Hemingway DM, Bell PR, Thompson MM (2001) Ubiquitous elevation of matrix metalloproteinase-2 expression in the vasculature of patients with abdominal aneurysms. Circulation 104:304

Article  CAS  PubMed  Google Scholar 

Miyake T, Morishita R (2009) Pharmacological treatment of abdominal aortic aneurysm. Cardiovasc Res 83:436

Article  CAS  PubMed  Google Scholar 

Nagashima H, Aoka Y, Sakomura Y et al (2002) A 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, cerivastatin, suppresses production of matrix metalloproteinase-9 in human abdominal aortic aneurysm wall. J Vasc Surg 36:158–163

Article  PubMed  Google Scholar 

Paraskevas KI, Stathopoulos V, Mikhailidis DP (2008) Pleiotropic effects of statins: implications for a wide range of diseases. Curr Vasc Pharmacol 6:237–239

Article  CAS  PubMed  Google Scholar 

Saratzis A, Kitas GD, Saratzis N, Melas N (2010) Can statins suppress the development of abdominal aortic aneurysms? A review of the current evidence. Angiology 61:137

Article  CAS  PubMed  Google Scholar 

Shiraya S, Miyake T, Aoki M et al (2009) Inhibition of development of experimental aortic abdominal aneurysm in rat model by atorvastatin through inhibition of macrophage migration. Atherosclerosis 202:34–40

Article  CAS  PubMed  Google Scholar